Case study A 24-year-old man attends with a new rash on the extensor surfaces of his arms and legs. He had noticed his nails have started to become brittle. He is concerned about the cosmetic appearance as he has just started a new job. His mother suffers with psoriasis
This is psoriasis, specifically plaque psoriasis.
Psoriasis often presents under the age of 30 with a second group of patients who develop the condition in their 50s. The rash is symmetrical and, as in this case, involves the extensor surfaces of the body. In chronic plaque psoriasis, the individual patches have a red base with an overlying silvery scale. Often psoriasis is mild with a few patches on the elbows and knees and a flaky scalp. For patients with more severe chronic plaque psoriasis, the condition can affect daily living significantly and lead to low mood, similar to other chronic diseases.
Psoriasis can present in many other ways, including in the flexures, isolated on the scalp, guttate psoriasis, palmoplantar psoriasis, pustular psoriasis and psoriatic arthropathy.
The exact cause of psoriasis is not fully understood, but research over the last few years has identified some causes that have been covered in previous InnovAiT articles. As in this case, there is a strong genetic link. Stress can precipitate the first presentation as well as be a trigger for subsequent exacerbations. Infection (e.g. with Streptococcus) can trigger psoriasis, particularly guttate psoriasis. Psoriasis localises around scars and areas of injury, which is called the Koebner phenomenon.
Diagnosis is clinical. A full history may enable triggers to be identified and advice on avoidance of these can improve the disease course. Different topical treatments can be prescribed to reduce the severity of the rash. Specific treatments are outlined in the National Institute for Health and Care Excellence (NICE) guidance on psoriasis, referenced below. Topical steroids, coal tar, dithranol and calcipotriol and regular emollients are used. More severe resistant cases can respond to light therapy and systemic agents, such as methotrexate and ciclosporin. These patients should be referred to a dermatologist.
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